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Background: New-onset atrial fibrillation in patients hospitalized for an acute myocardial infarction often leads to
hemodynamic deterioration and has serious adverse prognostic implications; mortality is particularly high in
patients with congestive heart failure and/or a reduced left ventricular ejection fraction. The mechanism of atrial
fibrillation in the context of an acute myocardial infarction has not been well characterized and an effective
treatment other than optimal medical therapy and mechanical hemodynamic support are expected.
Case presentation: A 71 year-old male with an acute myocardial infarction due to an occlusion of the left main
coronary artery was treated with percutaneous coronary intervention. He had developed severe congestive heart
failure with a left ventricular ejection fraction of 34%. The systemic circulation was maintained with an intraaortic
balloon pump, continuous hemodiafiltration, and mechanical ventilation until atrial fibrillation occurred on day 3
which immediately led to cardiogenic shock. Because atrial fibrillation was refractory to intravenous amiodarone,
beta-blockers, and a total of 15 electrical cardioversions, the patient underwent emergent radiofrequency catheter
ablation on day 4. Soon after electrical cardioversion, ectopies from the right superior pulmonary vein triggered the
initiation of atrial fibrillation. The right pulmonary veins were isolated during atrial fibrillation. Again, atrial fibrillation
was electrically cardioverted, then, sinus rhythm was restored. Subsequently, the left pulmonary veins were isolated.
The stabilization of the hemodynamics was successfully achieved with an increase in the blood pressure and urine
volume. Hemodiafiltration and amiodarone were discontinued. The patient had been free from atrial fibrillation
recurrence until he suddenly died due to ventricular fibrillation on day 9.
Conclusions: To the best of our knowledge, this is the first report of pulmonary vein isolation for a rescue purpose
applied in a patient with hemodymically unstable atrial fibrillation complicated with an acute myocardial infarction.
This case demonstrates that ectopic activity in the pulmonary veins may be responsible for triggering atrial
fibrillation in the critical setting of an acute myocardial infarction and thus pulmonary vein isolation could be an
effective therapeutic option.
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New-onset atrial fibrillation (AF) in patients hospitalized
for an acute myocardial infarction (AMI) often leads to
hemodynamic deterioration and has serious adverse
prognostic implications; mortality is particularly high in
patients with congestive heart failure and/or a reduced
left ventricular (LV) ejection fraction [1,2]. The mechan-
ism of AF in the context of an AMI has not been well
characterized, and little has been published on the man-
agement strategies for AF in this setting.
Case presentation
A 71-year-old male with an AMI due to a total occlusion
of the left main coronary artery was treated with emer-
gent percutaneous coronary intervention. The patient
had no history of AF and was in sinus rhythm on admis-
sion to the coronary care unit. He had developed severe
congestive heart failure and was on mechanical ventila-
tion under intravenous sedation with midazolam. Echo-
cardiography revealed an LV ejection fraction of 34%
and a left atrial (LA) diameter of 46 mm. The systemic
circulation was maintained with an intravenous adminis-
tration of inotropes, an intraaortic balloon pump (IABP),
and continuous hemodiafiltration (CHDF). Soon after
admission, the patient had several episodes of ventricular
tachycardia that required electrical cardioversion toFigure 1 Changes in hemodynamics before and after pulmonary vein
shown by the decrease in blood pressure and in urine volume. Pulmonary
hemodynamics. Solid arrows indicate electrical cardioversion to terminate a
terminate ventricular tachycardia. CHDF = continuous hemodiafiltration; IABterminate. Intravenous administration of amiodarone
was initiated, and this effectively suppressed the tachy-
cardia. However, AF occurred on day 3, which immedi-
ately led to cardiogenic shock. Because AF was
refractory to amiodarone, beta-blockers, and a total of
15 electrical cardioversions, the patient underwent
radiofrequency catheter ablation on day 4 (Figure 1).
Written informed consent was obtained from the
patient’s spouse.
Prior to electrophysiological evaluation, the patency of
the stented coronary artery was confirmed by coronary
angiography. A decapolar catheter was positioned in the
coronary sinus for pacing and used as a reference for the
NavX (St. Jude Medical, St Paul, MN) system. Transsep-
tal access was obtained using the standard Broken-
brough needle technique with intracardiac ultrasound
and fluoroscopic guidance. Three 8 F SL0 sheaths were
placed in the LA. Following pulmonary vein (PV) venog-
raphy, the cardiac geometry was created by a 20-pole
circular mapping catheter in all PVs, the LA appendage
and the body of the LA. In order to identify the trigger-
ing vein, four electrode catheters were positioned in the
following thoracic veins: a decapolar catheter in the su-
perior vena cava, an 8-mm tip ablation catheter (Ablaze,
Japan Lifeline, Japan) in the right superior PV, and two
circular mapping catheters in the left superior PV andisolation. Atrial fibrillation led to deterioration of hemodynamics as
vein isolation restored sinus rhythm and successfully improved
trial fibrillation; dotted arrows indicate electrical cardioversion to
P = intraaortic balloon pump.
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cardioversion, ectopies from the right superior PV trig-
gered the initiation of AF (Figure 2). This phenomenon
was reproducibly observed with the circular mapping
catheters repositioned in the right superior PV and right
inferior PV, respectively. Accordingly, the right PVs were
circumferentially isolated at antrum during AF with the
8-mm tip ablation catheter at a power of 30–35 W
under the guidance of a NavX 3D navigation system.
Again, AF was electrically cardioverted, and sinus
rhythm was restored (Figure 3). Subsequently, the left
PVs were circumferentially isolated from LA (Figure 3).
The absence of bidirectional PV-LA dormant conduc-
tion was confirmed by intravenous injection of 40 mg of
adenosine. The stabilization of the hemodynamics was
successfully achieved with an increase in the blood pres-
sure and urine volume (Figure 1). CHDF and amiodar-
one were discontinued on days 5 and 6, respectively.
Weaning from mechanical ventilation and intravenous
dopamine was also initiated. The patient was free from
AF recurrence until he suddenly died due to ventricular
fibrillation on day 9.
Discussion
To our knowledge, this is the first report of PV isolation
(PVI) for a rescue purpose applied in a patient with
hemodynamically unstable AF complicated with an
AMI. The present case includes two major findings.
First, AF may be triggered by ectopies from the PVs in
the critical setting of AMI. Second, PVI may be effectiveFigure 2 A: The spontaneous onset of atrial fibrillation triggered by e
right superior pulmonary vein preceded P wave by 63 ms. B: Fluoroscopic
patient was on intra-aortic balloon pump during the procedure due to sev
balloon pump; LSPV = left superior pulmonary vein; LIPV = left inferior pulm
vena cava; dist = distal bipole; prox = proximal bipole.for rhythm control and may thereby improve hemo-
dynamic status.
AF, especially a new onset of AF, has been shown to be
an independent predictor of mortality in patients with
AMI [1,2]. AF may cause adverse hemodynamic effects,
such as loss of atrial contraction, rapid ventricular rates,
loss of atrioventricular synchrony, and an irregular RR
interval, leading to a decrease in cardiac output [3].
Thus, when the patients are complicated with congestive
heart failure, the development of AF should have greater
adverse clinical significance than in cases without heart
failure [4]. Systemic circulation may collapse immedi-
ately. Even if it does not, insufficient coronary flow due
to decreased cardiac output may lead not only to delay-
ing the myocardial healing process but also to further
myocardial damage, which starts a vicious cycle of
hemodynamic deterioration. In this setting, AF could be
a lethal arrhythmia. The present case is a typical ex-
ample. The hemodynamics were barely maintained dur-
ing sinus rhythm with the mechanical support of an
IABP, but they immediately deteriorated due to the de-
velopment of AF.
Despite the increasing evidence showing the prognos-
tic significance of AF in patients with AMI, current
therapeutic strategies in this setting seem to be limited
to the management of hemodynamics, including IABP,
mechanical ventilation, CHDF, and so forth. In addition,
sedation with opioid analgesic drugs such as sufentanil
might provide some cardioprotective / antiarrhythmic
effects. These are the therapies generally given to AMI
patients with congestive heart failure, but are not actopies from the right superior pulmonary vein. * The potential of
AP image demonstrating positions of the electrode catheters. The
ere congestive heart failure. CS: coronary sinus; IABP = intraaortic
onary vein; RSPV = right superior pulmonary vein; SVC = superior
Figure 3 Pulmonary vein isolation. A: Baseline intracardiac electrograms of the right pulmonary veins before isolation during atrial fibrillation.
B: Intracardiac electrograms of the right pulmonary veins after isolation. Sinus rhythm was restored by an electrical cardioversion following
isolation of the right pulmonary veins. C: Baseline intracardiac electrograms of the left pulmonary veins before isolation during pacing from the
distal bipoles of coronary sinus. D: Intracardiac electrograms of the left pulmonary veins after isolation. E: Three-dimensional map (NavX, St. Jude
Medical) with white dots representing RF ablation lesions. LAA = left atrial appendage; RIPV = right inferior pulmonary vein. Other abbreviations
as in Figure 2.
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be accepted as an alternative to sinus rhythm restor-
ation. However, attempts at rate control often fail when
patients are on high levels of endogenous or exogenous
catecholamines or are not able to tolerate the use of
drugs including beta-blockers, digoxin, and calcium
antagonists, because these agents have negative inotropic
effects or may increase oxygen consumption. Further-
more, sinus rhythm should be necessary to maintain sys-
temic circulation in patients with severe pump failure as
shown in the present case. Amiodarone might be a drug
that can be used in this setting [4]. However, observa-
tional data recently suggested that an amiodarone-based
rhythm control strategy in patients with AF after AMI
complicated by heart failure or LV dysfunction is asso-
ciated with excess early mortality when compared with
the rate control strategy [5].
PVI has been accepted by consensus as the strategy of
choice for the treatment of AF by catheter ablation [6].
PVI exerts its beneficial effects by autonomic denerv-
ation of LA, by eliminating part of the arrhythmogenic
substrate, and most importantly by eliminating AF trig-
gers arising from PVs [6,7]. However, it is not clear
whether PVI also functions well in the setting of AMI
where multiple precipitating factors may be involved in
the development of AF. Those factors may include in-
flammation, acute hypoxia or hypokalaemia, endogenous
or exogenous catecholamines, right ventricular infarc-
tion, and atrial ischemia [8]. Hemodynamic impairment
secondary to LV dysfunction such as a high pulmonaryartery wedge pressure as well as right atrial pressure re-
late to the development of AF [9]. The present case
demonstrated that PVs play an important role as a
source of AF triggers in this setting. PV-stretch due to
elevated PV pressure might contribute to the triggering
substrate [10]. Although the patient died due to ven-
tricular fibrillation, PVI successfully brought the patient
back into sinus rhythm and clearly improved his
hemodynamic status.
Based on this single case report, it is premature to
draw conclusions that PVI could become a standard
procedure to treat AF in the critical setting of an AMI.
Since PVI is still a highly complex procedure, a careful
assessment of benefit and risk must be considered for
each patient.
Conclusions
Ectopic activity in the PVs may be responsible for trig-
gering AF in the critical setting of an AMI. PVI in des-
perate cases, as a last resort, is feasible and could be an
effective therapeutic option.
Consent
Written informed consent was obtained from the
patient’s spouse for publication of this case report and
accompanying images.
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